Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer

JEA Portielje, Wim Kruit, M Schuler, J Beck, CHJM Lamers, Gerrit Stoter, C Huber, M Boer-Dennert, A Rakhit, RLH (Reinder) Bolhuis, WE Aulitzky

Research output: Contribution to journalArticleAcademicpeer-review

106 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)3983-3989
Number of pages7
JournalClinical Cancer Research
Publication statusPublished - 1999

Research programs

  • EMC MM-03-86-12

Cite this